Heartbeam, Inc. (BEAT)
Nasdaq: BEAT · Surgical & Medical Instruments & Apparatus · Santa Clara, CA · filing with the SEC since 2019
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 12, 2026 | Mar 13, 2025 | Mar 20, 2024 | Mar 16, 2023 | Mar 24, 2022 | · |
| Research and development | 13,450 | 11,051 | 6,798 | 5,677 | 255 | 133 |
| General and administrative | 7,689 | 8,836 | 8,516 | 7,354 | 2,030 | 655 |
| Total operating expenses | 21,139 | 19,887 | 15,314 | 13,031 | 2,285 | 788 |
| Operating income | -21,139 | -19,887 | -15,314 | -13,031 | -2,285 | -788 |
| Interest expense | · | · | · | · | 2,165 | 280 |
| Interest income (expense), net | 122 | 446 | 675 | 66 | -2,165 | · |
| Other income (expense), net | 2 | -7 | 0 | 3 | 22 | 0 |
| Total non-operating income (expense) | 124 | 439 | 675 | 69 | -2,143 | -280 |
| Income before income taxes | -21,015 | -19,448 | -14,639 | -12,962 | -4,428 | -1,068 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Income from continuing operations | -21,015,000 | -19,448,000 | · | · | · | · |
| Net income | -21,015 | -19,448 | -14,639 | -12,962 | -4,428 | -1,068 |
| Earnings per share, basic | -0.62 | -0.73 | -0.72 | -1.59 | -1.03 | -0.29 |
| Earnings per share, diluted | -0.62 | -0.73 | -0.72 | -1.59 | -1.03 | -0.29 |
| Weighted average shares, basic | 33,710,095 | 26,645,228 | 20,333,280 | 8,168,516 | 4,284,714 | 3,645,944 |
| Weighted average shares, diluted | 33,710,095 | 26,645,228 | 20,333,280 | 8,168,516 | 4,284,714 | 3,645,944 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitIncome from continuing operations profit from the businesses it keeps
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding